Latest Portfolio Companies News

MedAdvisor Limited has finalized the sale of its Australian and New Zealand operations to Jonas Software for an estimated $42.35 million, marking a strategic pivot towards its US business. The company also announced upcoming CFO changes as it refocuses its growth trajectory.

MedAdvisor Limited has entered a binding agreement to sell its ANZ business division and intellectual property to Jonas Software for a headline price of $35 million plus an uncapped earn-out. The deal marks a strategic pivot as MedAdvisor focuses on its US operations.

Bailador Technology Investments has updated its portfolio valuations, revealing strong gains in key holdings and a projected gross return of 32.8% for FY25. However, one investment saw a significant decline, tempering overall optimism.

CD Private Equity Fund II reported a steep decline in net profit for FY25, with earnings per unit plunging 98%, yet continued to deliver solid distributions to unitholders amid a challenging US private equity market.

CD Private Equity Fund III reported a remarkable 726.6% jump in net profit to $18.56 million for FY25, driven by strong fair value gains and portfolio realizations. The Fund declared a $0.20 per unit distribution amid ongoing geopolitical and market challenges.

CD Private Equity Fund I reported a 43% decline in net profit for FY25 but maintained steady distributions, underpinned by key portfolio exits and a resilient US private equity market.

Infratil Limited reported a robust FY2025 with operational EBITDAF nearing NZ$1 billion, driven by strong performances across its core infrastructure sectors and a strategic capital raise to fuel CDC Data Centres’ expansion.

CD Private Equity Fund II announces an early distribution of $0.12 per unit, reflecting strong portfolio exits and delivering a 1.62x return since inception.

Touch Ventures Limited reported a substantial $24.9 million net loss for 2024, driven by impairments in legacy investments, while strategically pivoting with new stakes in Tixel and Reshop and welcoming Gannet Capital as a major shareholder.

Sandon Capital Investments has reported a robust 17.7% portfolio return for the half-year ending December 2024, driving net profits up to $16.78 million and announcing an increased fully franked dividend yield of 6.8%.

Gyder Surgical, backed by Hydrix Ventures, has secured FDA 510(k) clearance for its innovative GYDER Hip System, opening the door to the lucrative U.S. market and increasing Hydrix’s investment value.